Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-14

Clinical Trial Update: An Study of Efficacy and Safety of Clevudine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of clevudine for chronic hepatitis B has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clevudine (clevudine)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED